Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
Table 2
Clinical and laboratory characteristics of patients with various MPVLR values on admission.
Low group (,)
High group (,)
Gender (male/female)
9/41
9/42
0.831
Age (years)
0.193
Total protein (g/L)
60.0 (55.3-66.6)
59.7 (55.8-64.5)
0.847
Albumin (g/L)
30.0 (25.8-33.2)
28.9 (26.4-32.1)
0.407
AST (U/L)
52.5 (35.0-74.0)
47.0 (29.0-70.8)
0.262
Serum creatinine (μmol/L)
74.0 (62.0-84.0)
74.0 (60.3-98.5)
0.755
Total bilirubin (μmol/L)
41.5 (21.0-103.0)
68.0 (27.8-154.3)
0.097
INR
0.032
MPV (fl)
15.1 (13.8-17.5)
16.8 (13.6-19.5)
0.039
Lymphocyte count (×109/L)
1.40 (1.20-2.10)
0.70 (0.50-0.80)
<0.001
MPVLR
9.9 (8.4-12.0)
25.3 (18.8-37.6)
<0.001
PLTs (×109/L)
91.0 (65.0-159.0)
44.0 (28.8-80.0)
<0.001
MELD score
10.9 (6.3-17.8)
15.2 (11.8-17.8)
0.011
CP score
9.0 (8.0-11.0)
9.0 (8.3-11.0)
0.140
Data are expressed as ,, or median (interquartile range). Abbreviations: ALT: alanine aminotransferase; AST: aspartate aminotransferase; INR: international normalized ratio; MPV: mean platelet volume; MPVLR: mean platelet volume/lymphocyte ratio; PLTs: platelet counts; MELD score: model for end-stage liver disease score; CP score: Child-Pugh score; HBV-DC: HBV-related-decompensated cirrhosis.
